These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 2122894)

  • 1. Purification of the pyocin S2 complex from Pseudomonas aeruginosa PAO1: analysis of DNase activity.
    Seo Y; Galloway DR
    Biochem Biophys Res Commun; 1990 Oct; 172(2):455-61. PubMed ID: 2122894
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Molecular structures and functions of pyocins S1 and S2 in Pseudomonas aeruginosa.
    Sano Y; Matsui H; Kobayashi M; Kageyama M
    J Bacteriol; 1993 May; 175(10):2907-16. PubMed ID: 8491711
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification and functional analysis of a bacteriocin, pyocin S6, with ribonuclease activity from a Pseudomonas aeruginosa cystic fibrosis clinical isolate.
    Dingemans J; Ghequire MG; Craggs M; De Mot R; Cornelis P
    Microbiologyopen; 2016 Jun; 5(3):413-23. PubMed ID: 26860427
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cytotoxic effects of pyocin S2 produced by Pseudomonas aeruginosa on the growth of three human cell lines.
    Abdi-Ali A; Worobec EA; Deezagi A; Malekzadeh F
    Can J Microbiol; 2004 May; 50(5):375-81. PubMed ID: 15213746
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pore-forming pyocin S5 utilizes the FptA ferripyochelin receptor to kill Pseudomonas aeruginosa.
    Elfarash A; Dingemans J; Ye L; Hassan AA; Craggs M; Reimmann C; Thomas MS; Cornelis P
    Microbiology (Reading); 2014 Feb; 160(Pt 2):261-269. PubMed ID: 24217175
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of iron concentration in the growth medium on the sensitivity of Pseudomonas aeruginosa to pyocin S2.
    Ohkawa I; Shiga S; Kageyama M
    J Biochem; 1980 Jan; 87(1):323-31. PubMed ID: 6766926
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Purification and properties of an S-type pyocin, pyocin AP41.
    Sano Y; Kageyama M
    J Bacteriol; 1981 May; 146(2):733-9. PubMed ID: 6783626
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Discovery, characterization and in vivo activity of pyocin SD2, a protein antibiotic from Pseudomonas aeruginosa.
    McCaughey LC; Josts I; Grinter R; White P; Byron O; Tucker NP; Matthews JM; Kleanthous C; Whitchurch CB; Walker D
    Biochem J; 2016 Aug; 473(15):2345-58. PubMed ID: 27252387
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Structures of the Ultra-High-Affinity Protein-Protein Complexes of Pyocins S2 and AP41 and Their Cognate Immunity Proteins from Pseudomonas aeruginosa.
    Joshi A; Grinter R; Josts I; Chen S; Wojdyla JA; Lowe ED; Kaminska R; Sharp C; McCaughey L; Roszak AW; Cogdell RJ; Byron O; Walker D; Kleanthous C
    J Mol Biol; 2015 Aug; 427(17):2852-66. PubMed ID: 26215615
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pyocin S2 (Sa) kills Pseudomonas aeruginosa strains via the FpvA type I ferripyoverdine receptor.
    Denayer S; Matthijs S; Cornelis P
    J Bacteriol; 2007 Nov; 189(21):7663-8. PubMed ID: 17720787
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Biochemical properties of a new flexuous bacteriocin, pyocin F1, produced by Pseudomonas aeruginosa.
    Kuroda K; Kageyama M
    J Biochem; 1979 Jan; 85(1):7-19. PubMed ID: 104991
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Construction and characterization of pyocin-colicin chimeric proteins.
    Kageyama M; Kobayashi M; Sano Y; Masaki H
    J Bacteriol; 1996 Jan; 178(1):103-10. PubMed ID: 8550402
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Preferential inhibition of lipid synthesis by the bacteriocin pyocin S2.
    Okawa I; Maruo B; Kageyama M
    J Biochem; 1975 Jul; 78(1):213-23. PubMed ID: 811653
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Molecular Structure and Functional Analysis of Pyocin S8 from Pseudomonas aeruginosa Reveals the Essential Requirement of a Glutamate Residue in the H-N-H Motif for DNase Activity.
    Turano H; Gomes F; Domingos RM; Degenhardt MFS; Oliveira CLP; Garratt RC; Lincopan N; Netto LES
    J Bacteriol; 2020 Oct; 202(21):. PubMed ID: 32817098
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The pyocins of Pseudomonas aeruginosa.
    Michel-Briand Y; Baysse C
    Biochimie; 2002; 84(5-6):499-510. PubMed ID: 12423794
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Isolation, purification and characterization of a pyocin.
    Faydi YR; Nabbut NH
    Ann Microbiol (Paris); 1978 Apr; 129(3):313-22. PubMed ID: 96719
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Molecular characterization of pyocin S3, a novel S-type pyocin from Pseudomonas aeruginosa.
    Duport C; Baysse C; Michel-Briand Y
    J Biol Chem; 1995 Apr; 270(15):8920-7. PubMed ID: 7721800
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A predicted S-type pyocin shows a bactericidal activity against clinical Pseudomonas aeruginosa isolates through membrane damage.
    Ling H; Saeidi N; Rasouliha BH; Chang MW
    FEBS Lett; 2010 Aug; 584(15):3354-8. PubMed ID: 20580355
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The inherent DNase of pyocin AP41 causes breakdown of chromosomal DNA.
    Sano Y
    J Bacteriol; 1993 Feb; 175(3):912-5. PubMed ID: 8423163
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibition of Neisseria gonorrhoeae by a bacteriocin from Pseudomonas aeruginosa.
    Morse SA; Vaughan P; Johnson D; Iglewski BH
    Antimicrob Agents Chemother; 1976 Aug; 10(2):354-62. PubMed ID: 825024
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.